Earlier that day, stocks witnessed a gap at the start of the session. Stock prices were high at Rs 1063.75 for 52 weeks and low at Rs 660.1 for 52 weeks. NSE.. Approximately 19444 shares changed hands at the counter until 1:26 pm (IST).
The stock opened at Rs 755.6 and touched the daytime highs and lows of Rs 755.65 and Rs 746.9 during previous sessions. The counter estimates that the price-earnings ratio (PE) is 8.19, the earnings per share (EPS) is 90.87 rupees, the price-to-book value ratio (PB) is 2.36, and the return on equity (ROE) is 24.32 rupees.
Promoter / FII Holding
The promoter held a 51.83% stake in the company as of September 17, while FII and MF owned 25.65% and 9.03%, respectively.
With a market capitalization of Rs 43628.99, the company operates in the Indian pharmaceutical industry. Consolidated sales for the quarter ended June 30, 2021 were Rs 57,382 million, down 4.87% from the previous quarter and Rs 60.96 billion, down 4.26% from the same period last year. The company reported net income of Rs 769.97 in the most recent quarter, down 1.36 percent from the corresponding quarter last year.
The Relative Strength Index (RSI) of stocks is 42.73. The RSI varies between 0 and 100. Traditionally, an RSI value above 70 is considered overbought and below 30 is considered oversold. Receive trading calls in the same way that fundamental analysts cannot give “buy” or “sell” recommendations using a single valuation ratio.
Aurobindo Pharma Shares: As Sensex rises, Aurobindo Pharma shares fall 0.55%
https://economictimes.indiatimes.com/markets/stocks/stock-watch/aurobindo-pharma-shares-down-0-55-as-sensex-rises/articleshow/86287056.cms Aurobindo Pharma Shares: As Sensex rises, Aurobindo Pharma shares fall 0.55%